AGD delivered ~86,000 whole genomes in 2023, including a unique diverse ancestry cohort Expanded pharma engagement enhances AGD's ability to develop multiomic datasets SAN DIEGO, Jan. 4, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced three new memb ...